Literature DB >> 29262349

Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors.

Binqing Fu1, Yonggang Zhou1, Xiang Ni1, Xianhong Tong2, Xiuxiu Xu1, Zhongjun Dong3, Rui Sun1, Zhigang Tian4, Haiming Wei5.   

Abstract

Natural killer (NK) cells are present in large populations at the maternal-fetal interface during early pregnancy. However, the role of NK cells in fetal growth is unclear. Here, we have identified a CD49a+Eomes+ subset of NK cells that secreted growth-promoting factors (GPFs), including pleiotrophin and osteoglycin, in both humans and mice. The crosstalk between HLA-G and ILT2 served as a stimulus for GPF-secreting function of this NK cell subset. Decreases in this GPF-secreting NK cell subset impaired fetal development, resulting in fetal growth restriction. The transcription factor Nfil3, but not T-bet, affected the function and the number of this decidual NK cell subset. Adoptive transfer of induced CD49a+Eomes+ NK cells reversed impaired fetal growth and rebuilt an appropriate local microenvironment. These findings reveal properties of NK cells in promoting fetal growth. In addition, this research proposes approaches for therapeutic administration of NK cells in order to reverse restricted nourishments within the uterine microenvironment during early pregnancy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aged pregnancy; decidual NK cells; fetal development; fetal growth restriction; growth-promoting factors; maternal-fetal interface; tissue-resident NK

Mesh:

Substances:

Year:  2017        PMID: 29262349     DOI: 10.1016/j.immuni.2017.11.018

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  84 in total

Review 1.  Impact of maternal HIV exposure, feeding status, and microbiome on infant cellular immunity.

Authors:  Sonwabile Dzanibe; Heather B Jaspan; Michael Z Zulu; Agano Kiravu; Clive M Gray
Journal:  J Leukoc Biol       Date:  2018-12-21       Impact factor: 4.962

Review 2.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

Review 3.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.

Authors:  Laura J Yockey; Akiko Iwasaki
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

Review 4.  The Fetal-Maternal Immune Interface in Uterus Transplantation.

Authors:  Jasper Iske; Abdallah Elkhal; Stefan G Tullius
Journal:  Trends Immunol       Date:  2020-03       Impact factor: 16.687

5.  The role of natural killer cells in the uterine microenvironment during pregnancy.

Authors:  Julia P Andreotti; Ana E Paiva; Pedro H D M Prazeres; Daniel A P Guerra; Walison N Silva; Rogerio S Vaz; Akiva Mintz; Alexander Birbrair
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

Review 6.  Hemochorial placentation: development, function, and adaptations.

Authors:  Michael J Soares; Kaela M Varberg; Khursheed Iqbal
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

7.  Three macrophage subsets are identified in the uterus during early human pregnancy.

Authors:  Xiangxiang Jiang; Mei-Rong Du; Min Li; Hongmei Wang
Journal:  Cell Mol Immunol       Date:  2018-04-04       Impact factor: 11.530

Review 8.  Uterine natural killer cells: To protect and to nurture.

Authors:  Dorothy K Sojka; Liping Yang; Wayne M Yokoyama
Journal:  Birth Defects Res       Date:  2018-11-22       Impact factor: 2.344

9.  CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells.

Authors:  Luke Riggan; Andrew D Hildreth; Marion Rolot; Yung-Yu Wong; William Satyadi; Ryan Sun; Christopher Huerta; Timothy E O'Sullivan
Journal:  Cell Rep       Date:  2020-05-19       Impact factor: 9.423

10.  IFNs Drive Development of Novel IL-15-Responsive Macrophages.

Authors:  Scott M Gordon; Mailyn A Nishiguchi; Julie M Chase; Sneha Mani; Monica A Mainigi; Edward M Behrens
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.